These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 494957)

  • 1. Effect of infusion of dextran 70 on fibrinolysis inhibition activity in human serum.
    Carlin G; Modig J; Saldeen T
    Acta Chir Scand; 1979; 145(3):129-31. PubMed ID: 494957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of dextran on fibrinolysis inhibition activity in the blood after major surgery.
    Carlin G; Karlström G; Modig J; Saldeen T
    Acta Anaesthesiol Scand; 1980 Oct; 24(5):375-8. PubMed ID: 6162353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Coagulation-physiological studies on the prevention of thromboembolism with dextran 60. II. Changes in coagulation and fibrinolysis].
    Briel RC; Kunz S; Kidess E
    Infusionsther Klin Ernahr; 1977 Oct; 4(5):299-303. PubMed ID: 562322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dextran on fibrinolysis inhibition activity in serum.
    Carlin G; Saldeen T
    Thromb Res; 1978 Jun; 12(6):1165-75. PubMed ID: 151346
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravenous versus intraperitoneal administration of dextran in the rabbit: effects on fibrinolysis.
    Wagaman R; Ingram JM; Rao PS; Saba HI
    Am J Obstet Gynecol; 1986 Sep; 155(3):464-70. PubMed ID: 2428247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of dextran and gelatin infusion on the coagulation and fibrinolytic process in rabbits subjected to combined radiation injuries].
    Pantelić D; Ciko Z; Knezević O
    Zb Vojnomed Akad; 1976; (18):33-8. PubMed ID: 1074334
    [No Abstract]   [Full Text] [Related]  

  • 7. Blood fibrinolytic activity in diseases of small blood vessels and the effect of low molecular weight dextran.
    Cunliffe WJ; Menon IS
    Br J Dermatol; 1969 Mar; 81(3):220-5. PubMed ID: 5775073
    [No Abstract]   [Full Text] [Related]  

  • 8. Experience with low molecular weight dextran in patients with thrombocytosis.
    Tytgat GN; De Vreker RA; Lust A
    Acta Anaesthesiol Belg; 1968; 19(2):183-92. PubMed ID: 5746328
    [No Abstract]   [Full Text] [Related]  

  • 9. Induction of endogenous fibrinolysis inhibition in the dog. Effect of intravascular coagulation and release of free fatty acids.
    Lindquist O; Bagge L; Saldeen T
    Acta Chir Scand; 1976; 142(1):20-5. PubMed ID: 1266538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of postoperative thromboembolism by dextran 70 or low-dose heparin.
    Hohl MK; Lüscher KP; Tichý J; Stiner M; Fridrich R; Gruber UF; Käser O
    Obstet Gynecol; 1980 Apr; 55(4):497-500. PubMed ID: 6154272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dextran's antithrombotic properties in small arteries are not altered by low-molecular-weight heparin or the fibrinolytic inhibitor tranexamic acid: an experimental study.
    Zhang B; Wieslander JB
    Microsurgery; 1993; 14(4):289-95. PubMed ID: 7692212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of drugs and parenteral solutions on vascular fibrinolytic activity.
    Johnston WE; Silver D
    Surgery; 1975 Aug; 78(2):202-10. PubMed ID: 1154264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of 6 per cent dextran 70 Polfa transfusions on blood clotting and hemostasis].
    Rudowski W; Kostrzewska E; Meissner AJ; Lopaciuk S; Uszyński L
    Pol Tyg Lek; 1973 Oct; 28(41):1581-3. PubMed ID: 4765459
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects on the human fibrinolytic system of prolonged intravenous infusion of high doses of Complamin (xantinol nicotinate).
    Bouvier CA; Berthoud S
    Helv Med Acta; 1968 Mar; 34(2):170-86. PubMed ID: 4232105
    [No Abstract]   [Full Text] [Related]  

  • 15. The influence of heparin, tranexamic acid, and low molecular weight dextran on pulmonary microvascular occlusions following aortic cross-clamping.
    Lim RC; Bergentz SE
    Bibl Anat; 1969; 10():480-8. PubMed ID: 5407404
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of dextran on factor VIII and thrombus stability in humans. Significance of varying infusion rates.
    Aberg M; Arfors KE; Bergentz SE
    Acta Chir Scand; 1977; 143(7-8):417-9. PubMed ID: 345704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Platelet functions following dextran administration].
    Cronberg S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(4):491-6. PubMed ID: 4193166
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of oral administration of dextran sulphate in experimental pulmonary thromboembolism and cholesterol arteriosclerosis in rabbits].
    Koga M
    Igaku Kenkyu; 1971 Sep; 41(6):502-20. PubMed ID: 5168962
    [No Abstract]   [Full Text] [Related]  

  • 19. Peroperative infusion of dextran 70 and dextran 40 in the prevention of postoperative deep venous thrombosis as confirmed by the I-125-labelled fibrinogen uptake method.
    Huttunen H; Mattila MA; Alhava EM; Kettunen K; Karjalainen P; Poikolainen P; Huttunen K
    Ann Chir Gynaecol; 1977; 66(2):79-81. PubMed ID: 326133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Low molecular weight dextran and fibrinolysis in humans. I. Comparison between fibrinolysis activation by administering low molecular weight dextran by intravenous and intra-arterial routes].
    Tesi M; Brunetti S; Caramelli L
    Riv Crit Clin Med; 1967 Aug; 67(3):200-15. PubMed ID: 5633532
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.